phentolamine mesylate
phentolamine mesylate is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Ryzumvi. Available dosage form: solution/ drops.
Drug Details
- Generic Name
- phentolamine mesylate
- Brand Names
- Ryzumvi
- Application Number
- NDA217064
- Sponsor
- Oyster Point Pharma, Inc.
- NDC Codes
- 2
- Dosage Forms
- SOLUTION/ DROPS
- Routes
- OPHTHALMIC
- Active Ingredients
- PHENTOLAMINE MESYLATE
Indications and Usage
1. INDICATONS AND USAGE OraVerse an alpha adrenergic blocker, is indicated for adult and pediatric patients ages 3 years and older for the reversal of soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor. OraVerse, an alpha adrenergic blocker, is indicated for adult and pediatric patients ages 3 years and older for the reversal of soft-tissue anesthesia, i.e., anesthesia of the lip and tongue, and the associated functional deficits resulting from an intraoral submucosal injection of a local anesthetic containing a vasoconstrictor. ( 1 )